Pillai, Rathi N.
Emory University · Winship Cancer Institute
3 papers on CoChat
Most cited papers
- Verified
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
Antonia, S. J., López-Martin, J. A., Bendell, J., Ott, P. A., Taylor, M., Eder, J. P., Jäger, D., Pietanza, M. C., Le, D. T., de Braud, F., et al. (2016) · The Lancet Oncology
Lung Cancer Research StudiesCancer Immunotherapy and Biomarkers
Cited by 1,244
- Verified
Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
Kamphorst, A. O., Wieland, A., Nasti, T., Yang, S., Zhang, R., Barber, D. L., Konieczny, B. T., Daugherty, C. Z., Koenig, L., Yu, K., et al. (2017) · Science
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 1,015
- Verified
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
Kamphorst, A. O., Pillai, R. N., Yang, S., Nasti, T. H., Akondy, R. S., Wieland, A., Sica, G. L., Yu, K., Koenig, L., Patel, N. T., et al. (2017) · Proceedings of the National Academy of Sciences
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 854
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free